GFAP and myeloid sarcoma: In another meta-analysis, including 11 clinical trials comprising 960 MS patients, GFAP concentrations in the CSF were significantly elevated in MS patients compared to the healthy controls, and the mean levels of GFAP in the CSF were higher in PMS subjects compared to RRMS patients [39].